V. Bronte and P. Zanovello, Regulation of immune responses by L-arginine metabolism, Nature Reviews Immunology, vol.174, issue.8, pp.641-54, 2005.
DOI : 10.1128/IAI.72.5.2723-2730.2004

I. Marigo, L. Dolcetti, P. Serafini, and P. Zanovello, Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells, Immunological Reviews, vol.176, issue.1, pp.162-79, 2008.
DOI : 10.1158/0008-5472.CAN-06-4639

G. Rabinovich, D. Gabrilovich, and E. Sotomayor, Immunosuppressive Strategies that are Mediated by Tumor Cells, Annual Review of Immunology, vol.25, issue.1, pp.267-96, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141609

Y. Sawanobori, S. Ueha, M. Kurachi, T. Shimaoka, and J. Talmadge, Abe J Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice

L. Bingle and N. Brown, The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies, The Journal of Pathology, vol.7, issue.3, pp.254-65, 2002.
DOI : 10.1002/path.1027

D. Canioni, G. Salles, N. Mounier, N. Brousse, and M. Keuppens, High Numbers of Tumor-Associated Macrophages Have an Adverse Prognostic Value That Can Be Circumvented by Rituximab in Patients With Follicular Lymphoma Enrolled Onto the GELA-GOELAMS FL-2000 Trial, Journal of Clinical Oncology, vol.26, issue.3, pp.440-446, 2008.
DOI : 10.1200/JCO.2007.12.8298

C. Lewis and J. Pollard, Distinct Role of Macrophages in Different Tumor Microenvironments, Cancer Research, vol.66, issue.2, pp.605-617, 2006.
DOI : 10.1158/0008-5472.CAN-05-4005

K. Movahedi, M. Guilliams, J. Van-den-bossche, R. Van-den-bergh, and C. Gysemans, Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity, Blood, vol.111, issue.8, pp.4233-4277, 2008.
DOI : 10.1182/blood-2007-07-099226

C. Uyttenhove, L. Pilotte, I. Theate, V. Stroobant, and D. Colau, Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase, Nature Medicine, vol.9, issue.10, pp.1269-74, 2003.
DOI : 10.1038/nm934

R. Metz, J. Duhadaway, U. Kamasani, L. Laury-kleintop, and A. Muller, Novel Tryptophan Catabolic Enzyme IDO2 Is the Preferred Biochemical Target of the Antitumor Indoleamine 2,3-Dioxygenase Inhibitory Compound D-1-Methyl-Tryptophan, Cancer Research, vol.67, issue.15, pp.7082-7089, 2007.
DOI : 10.1158/0008-5472.CAN-07-1872

Y. Ma, L. Visser, H. Roelofsen, M. De-vries, A. Diepstra et al., Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes, Blood, vol.111, issue.4, pp.2339-2385, 2008.
DOI : 10.1182/blood-2007-09-112128

C. Fong, L. Burgoon, K. Williams, and A. Forgacs, Zacharewski TR Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice, BMC Genomics, vol.8, 2007.

N. Marshall, L. Christie, L. Munro, D. Culligan, P. Johnston et al., Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma, Blood, vol.103, issue.5, pp.1755-62, 2004.
DOI : 10.1182/blood-2003-07-2594

C. Copie-bergman, P. Gaulard, L. Maouche-chretien, J. Briere, C. Haioun et al., The MAL gene is expressed in primary mediastinal large B-cell lymphoma, Blood, vol.94, issue.10, pp.3567-75, 1999.

A. Schroder, P. Pavlidis, A. Arimura, D. Capece, and P. Rothman, Cutting Edge: STAT6 Serves as a Positive and Negative Regulator of Gene Expression in IL-4-Stimulated B Lymphocytes, The Journal of Immunology, vol.168, issue.3, pp.996-1000, 2002.
DOI : 10.4049/jimmunol.168.3.996

B. Skinnider, A. Elia, R. Gascoyne, B. Patterson, L. Trumper et al., Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma, Blood, vol.99, issue.2, pp.618-644, 2002.
DOI : 10.1182/blood.V99.2.618

K. Calvo, B. Dabir, A. Kovach, C. Devor, R. Bandle et al., IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma, Blood, vol.112, issue.9, pp.3818-3844, 2008.
DOI : 10.1182/blood-2008-02-138933

A. Rosenwald, G. Wright, K. Leroy, X. Yu, and P. Gaulard, Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma, The Journal of Experimental Medicine, vol.81, issue.6, pp.851-62, 2003.
DOI : 10.1084/jem.20022089

D. Yu, D. Cozma, and A. Park, Selection Assay Using a Myc-Induced B-Cell Tumor, Annals of the New York Academy of Sciences, vol.59, issue.1, pp.145-59, 2005.
DOI : 10.1196/annals.1339.047

E. Ghia, S. Jain, G. Widhopf, L. Rassenti, and M. Keating, Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection, Blood, vol.111, issue.10, pp.5101-5109, 2008.
DOI : 10.1182/blood-2007-12-130229

G. Finak, N. Bertos, F. Pepin, S. Sadekova, M. Souleimanova et al., Stromal gene expression predicts clinical outcome in breast cancer, Nature Medicine, vol.25, issue.5, pp.518-545, 2008.
DOI : 10.1038/nm1764

S. Roulland, F. Suarez, and H. O. , Pathophysiological aspects of memory B-cell development, Trends in Immunology, vol.29, issue.1, pp.25-33, 2008.
DOI : 10.1016/j.it.2007.10.005

URL : https://hal.archives-ouvertes.fr/hal-00294276